The purpose of this study is to test how safe and effective Volrustomig is when combined with other cancer treatments for people with specific types of tumors, specifically in the lung(s). The goal is to see if this combination can help treat the tumors better while being safe for patients.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Shetal Patel
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Lung)
24-1611
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
